SF1302

Senate File No. 1302 is a proposed law in Minnesota requiring health insurance plans to cover certain types of cancer-related tests. Specifically, it mandates coverage for cancer imaging and clinical genetic testing.

• Cancer Imaging: This refers to using advanced medical imaging technologies to detect cancer, based on the latest guidelines from the National Comprehensive Cancer Network (NCCN).
• Clinical Genetic Testing: This involves testing individuals for inherited gene mutations that may increase the risk of developing cancer, based on established clinical practice guidelines.

The bill specifies that these services should be covered without any cost-sharing by the patient, such as deductibles, copayments, or coinsurance. However, if covering these services without cost-sharing would make an individual ineligible for a health savings account or a catastrophic health plan under current U.S. laws, then the no-cost-sharing rule will only apply after the individual has met their deductible.

In essence, this bill aims to make it easier and potentially more affordable for individuals at risk of cancer to access important preventative and diagnostic tests without additional financial burden.